- Home
- ARWR vs NMIH Comparison
ARWR vs NMIH Comparison
Compare ARWR & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | NMIH |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 2.8B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARWR | NMIH |
|---|---|---|
| Price | $64.08 | $40.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $63.70 | $41.20 |
| AVG Volume (30 Days) | ★ 3.4M | 409.7K |
| Earning Date | 11-25-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.56 |
| EPS | N/A | ★ 4.79 |
| Revenue | ★ $829,448,000.00 | $692,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | ★ N/A | $8.37 |
| Revenue Growth | ★ 23258.15 | 8.86 |
| 52 Week Low | $9.57 | $31.90 |
| 52 Week High | $72.36 | $43.20 |
Technical Indicators
Market Signals| Indicator | ARWR | NMIH |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 71.43 |
| Support Level | $59.51 | $37.08 |
| Resistance Level | $72.36 | $38.90 |
| Average True Range (ATR) | 4.67 | 0.72 |
| MACD | -0.11 | 0.24 |
| Stochastic Oscillator | 59.17 | 91.72 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About NMIH NMI Holdings Inc.
NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.